Systematic review / meta-analysis / 2022
Arthrospira (Spirulina) supplementation significantly reduced fasting blood sugar, total cholesterol, and triglycerides, while increasing HDL-C in clinical studies.
A systematic review and meta-analysis of 7 clinical and 27 preclinical studies evaluated the effect of Arthrospira (Spirulina) on glycemic and lipid markers. In clinical studies, Arthrospira significantly reduced fasting blood sugar (MD -1.77, 95% CI -2.90 to -0.63), total cholesterol (MD -2.54, 95% CI -4.61 to -0.46), and triglycerides (MD -3.71, 95% CI -6.54 to -0.89), while increasing HDL-C (MD 2.27, 95% CI 0.67 to 3.86). However, it did not significantly reduce HbA1c (MD -0.59, 95% CI -2.23 to 1.04) or LDL-C in humans. Subgroup analyses showed significant FBS reductions with doses under 2 grams [-3.22 (-5.67, -0.76)] and durations under 2 months [-2.52 (-4.37, -0.67)].
- Study type
- Systematic review and meta-analysis
- Who was studied
- Human participants across 7 clinical studies (and 27 preclinical studies)
- What was measured
- Fasting blood sugar, HbA1c, total cholesterol, triglycerides, HDL-C, and LDL-C
THE PAPER
Effect of Microalgae Arthrospira on Biomarkers of Glycemic Control and Glucose Metabolism: A Systematic Review and Meta-analysis.
Ghanbari F, Amerizadeh A, Behshood P, Moradi S, Asgary S. Curr Probl Cardiol, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.